Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

Hogan Lovells Publications

Proposed measures in Germany for safeguarding supply of critical goods in the combat against COVID-19

In the wake of combating the COVID-19 pandemic, the German federal government is proposing to enable further measures on a federal level. The proposal includes important measures concerning ...

Hogan Lovells Publications

Life sciences and health care horizons 2020

We are pleased to provide you with the third annual installment of our Life Sciences and Health Care Horizons guide. For each of these guides, we have asked our industry thought leaders...

Hogan Lovells Publications

Online sale of pharmaceuticals in Russia remains prohibited and lawmakers are yet to pass the bill allowing online sales

Russian law currently prohibits the online sale of pharmaceuticals and requires that pharmaceuticals must be sold only in stationary pharmacies operated by a person holding a pharmaceutical ...

News

FDA’s ‘Project Facilitate’ Pilot to Collect Metrics on Sponsor Expanded Access Denials Focus On Regulation

This morning, the U.S. Food and Drug Administration (FDA) announced it launched its new expanded access pilot called "Project Facilitate," a concierge call center under the Oncology Center...

Published Works

China: Survival of the Fittest or Cheapest? Update Magazine

Senior Associate Xin Tao authored an article titled "China: Survival of the Fittest or Cheapest?" for Update magazine.

News

FDA guidance may ease path to biosimilar interchangeability Focus On Regulation

On 10 May 2019 the U.S. Food and Drug Administration (FDA) published the final guidance, "Considerations in Demonstrating Interchangeability With a Reference Product," which is intended to...

Hogan Lovells Publications

FDA doubles down on MUsT studies for sunscreens and issues final guidance on absorption studies that will likely be needed for continued marketing Focus On Regulation

On 10 May 2019 the U.S. Food and Drug Administration (FDA) published a notice of availability for a final guidance document on Maximal Usage Trials (MUsT studies) for topically applied...

Loading data